HOME    | Hepatitis B     | Hepatitis C  
<--- Return to the 56th AASLD Main Page
HIVandHepatitis.com Coverage of Highlights from the
56th Annual Meeting of the American
Association for the Study of Liver Diseases

 November 11 - 15, 2005 San Francisco, California


Genotypes

Treatment of Genotype 1 Chronic Hepatitis C: Increased Sustained Virological Response with High-dose RBV and Epoetin - 11/23/05

Do Higher Doses of Anti-HCV Treatment Increase Responses?: A Tale of 3 Studies - 11/21/05

Short-term Treatment Duration for HCV Genotypes 2 and 3 Patients - 11/18/05

Does Weight-based Ribavirin Dosing Increase Sustained Viral Response in Patients with Chronic Hepatitis C? Final Results of the WIN-R Study - 11/18/05

Pegetron Prospective Optimal Weight-based Dosing Response Program (POWeR): Preliminary Results - 11/14/05


Consensus Interferon in Combination with Gamma Interferon and/or Ribavirin Results in a Significant Virologic Response in Hepatitis C Genotype 1 Patients - 11/16/05

 

 



<--- Return to the 56th AASLD Main Page